Abstract
We have studied activity and toxicity of subcutaneous recombinant interleukin-2 and interferon α 2b in a series of 14 patients with advanced renal cell carcinoma. No objective response was observed, and the median survival was 16 months (range 3-19); toxicity was acceptable. All the patients had poor prognostic factors and were pretreated with interferon.
Original language | English |
---|---|
Pages (from-to) | 1137-1139 |
Number of pages | 3 |
Journal | Oncology Reports |
Volume | 3 |
Issue number | 6 |
Publication status | Published - 1996 |
Keywords
- interferon α
- interleukin-2
- renal cancer
ASJC Scopus subject areas
- Cancer Research
- Oncology